Raoul Herbrecht
Radboud University Medical Center
2 papers in the Anchorcite directory, published between 2002 and 2008, cited 10,584 times in total.
ORCID profileResearch topics
- Lymphoma Diagnosis and Treatment · 1 paper
- Viral-associated cancers and disorders · 1 paper
- CNS Lymphoma Diagnosis and Treatment · 1 paper
- Fungal Infections and Studies · 1 paper
- Antifungal resistance and susceptibility · 1 paper
- Neutropenia and Cancer Infections · 1 paper
Frequent co-authors
- Bertrand Coiffier · 1 paper
- Éric Lepage · 1 paper
- Josette Brière · 1 paper
- Hervé Tilly · 1 paper
- Réda Bouabdallah · 1 paper
- Pierre Morel · 1 paper
- Éric Van Den Neste · 1 paper
- Gilles Andre Salles · 1 paper
Papers
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine · 2002 · 5,644 citations
BACKGROUND: The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conducted a randomized trial to…
- Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupClinical Infectious Diseases · 2008 · 4,940 citations
BACKGROUND: Invasive fungal diseases are important causes of morbidity and mortality. Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such…
Metadata from OpenAlex (CC0).